garcinol has been researched along with Cancer of Esophagus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Lao, YZ; Lv, Y; Tan, HS; Wang, J; Wu, M; Xu, HX; Zhang, H; Zhang, L; Zheng, D; Zhou, H | 1 |
1 other study(ies) available for garcinol and Cancer of Esophagus
Article | Year |
---|---|
Garcinol inhibits esophageal cancer metastasis by suppressing the p300 and TGF-β1 signaling pathways.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; E1A-Associated p300 Protein; Esophageal Neoplasms; Garcinia; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Signal Transduction; Terpenes; Transforming Growth Factor beta1; Tumor Cells, Cultured; Wound Healing | 2020 |